...
首页> 外文期刊>The American Journal of Cardiology >Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention.
【24h】

Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention.

机译:经皮冠状动脉介入治疗稳定型心绞痛患者氯吡格雷治疗后内皮功能与残余血小板反应性的关系。

获取原文
获取原文并翻译 | 示例

摘要

Platelet reactivity is greater in patients with stable angina and with more extensive peripheral vascular atherosclerosis. We sought to evaluate whether impaired peripheral microcirculatory endothelial function might correlate with platelet reactivity after clopidogrel and therefore predispose to an unfavorable outcome after percutaneous coronary intervention (PCI). In 52 consecutive patients with stable angina undergoing elective PCI, endothelial function was assessed by (1) endothelial peripheral arterial tonometry (measuring the Endoscore co-factor activity. Basal platelet reactivity was assessed by soluble P-selectin. Patients then received a 600-mg clopidogrel loading dose > or = 12 hours before PCI. A blood sample was withdrawn 12 hours later, but before PCI, to assess platelet reactivity using the P2Y12 reaction unit and percentage of P2Y12 inhibition with the point-of-care VerifyNow P2Y12 assay. Troponin T was assessed 24 hours after PCI. The Endoscore inversely correlated with von Willebrandt factor antigen activity (r = -0.52, p = 0.0001) and soluble P-selectin concentration (r = -0.36, p = 0.021), suggesting greater platelet reactivity with increased impaired endothelial function. After clopidogrel, the Endoscore correlated directly with the percentage of P2Y12 inhibition (r = 0.36, p = 0.009) and inversely with the P2Y12 reaction unit (r = -0.41, p = 0.002), suggesting greater residual platelet reactivity with more impaired endothelial function. The average Endoscore was significantly lower in patients with troponin T elevation (troponin positive group 0.267 + or - 0.091) than in patients without troponin T elevation (troponin negative group 0.508 + or - 0.041, p = 0.015 vs troponin positive). In conclusion, an impaired endothelial response before clopidogrel was associated with greater platelet reactivity after clopidogrel. This link might explain the unfavorable PCI outcomes in patients with more severe endothelial impairment.
机译:稳定型心绞痛和较广泛的周围血管动脉粥样硬化患者的血小板反应性更高。我们试图评估氯吡格雷后外周微血管内皮功能受损是否与血小板反应性相关,因此在经皮冠状动脉介入治疗(PCI)后易患不良结局。在连续52例行稳定性心绞痛的择期PCI患者中,通过以下方式评估内皮功能:(1)内皮外周动脉眼压测量(测量Endoscore辅助因子活性。通过可溶性P-选择素评估基础血小板反应性,然后患者接受600 mg氯吡格雷负荷剂量>或=在PCI前12小时。在12小时后(但在PCI之前)抽取血样,以P2Y12反应单位评估血小板反应性,并通过即时点VerifyNow P2Y12测定法评估P2Y12抑制百分比。 PCI后24小时评估T,Endoscore与von Willebrandt因子抗原活性(r = -0.52,p = 0.0001)和可溶性P-选择素浓度(r = -0.36,p = 0.021)成反比,提示血小板反应性更高。氯吡格雷治疗后,Endoscore与P2Y12抑制百分比直接相关(r = 0.36,p = 0.009),与P2Y12反应单位成反比(r = -0.41,p = 0.002),提示更高的残留血小板反应性和更弱的内皮功能。肌钙蛋白T升高的患者(肌钙蛋白阳性组0.267 +或-0.091)的平均Endoscore显着低于没有肌钙蛋白T升高的患者(肌钙蛋白阴性的组0.508 +或-0.041,p = 0.015 vs肌钙蛋白阳性)。总之,氯吡格雷之前的内皮反应受损与氯吡格雷之后更高的血小板反应性有关。该链接可能解释了具有更严重内皮损伤的患者的不利PCI结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号